Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
EHA: J&J chalks up early-stage myeloma win for Talvey/Darzalex combo
J&J's MonumenTAL-3 phase 3 study of bispecific antibody Talvey and Darzalex Faspro in earlier-stage multiple myeloma earned a plenary spot at EHA.
Zoey Becker
Jun 13, 2026 6:00am
The Oral GLP-1 Tracker: Novo’s Wegovy keeps gaining ground
Jun 12, 2026 2:30pm
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
Amgen to file 3rd-party review of Tavneos data for FDA hearing
Jun 12, 2026 11:12am
Pharma marketers face privacy hurdles, turn to omnichannel strategies
Brought to you by
Swoop
Zepzelca saga takes another turn with ph. 3 lung cancer flop
Jun 12, 2026 10:48am
